The global threat of the "antimicrobial resistance apocalypse" that has arisen in recent years has driven the use of high-throughput sequencing techniques to monitor the profile of resistance genes, known as the "resistome", in microbial populations. The human oral cavity contains a poorly explored reservoir of these genes, and little is known about their abundance and diversity, or how their profile compares with antimicrobial resistance genes in the gut. Here we analyse the resistome profiles of 788 oral cavities worldwide and compare these profiles with paired stool samples from shotgun metagenomic data. We find country and body site-specific differences in the prevalence of antimicrobial resistance genes, classes and mechanisms in oral and stool samples. However, the abundance of these antimicrobial resistance classes do not correlate with antibiotic prescription rates. A greater similarity was found in interpersonal resistomes between the same body sites than intrapersonal resistomes across different body sites. Between individuals, the oral cavity contains the highest and lowest abundances of specific antimicrobial resistance genes, but a lower diversity of resistance genes compared to the gut, which is likely influenced by differences in microbial composition and exposure to antimicrobial selection pressures. Co-occurrence analysis shows contrasting ARG-species associations between saliva and stool samples. This is the first study to date that characterises the oral cavity resistome worldwide, identifying its distinctive signatures compared to the gut.Maintenance and persistence of antimicrobial resistance is likely to vary across different body sites. Thus, we highlight the importance of characterising the resistome across body sites to uncover the antimicrobial resistance potential in the human body.
Introduction
In recent years, antimicrobial resistance (AMR) has been highlighted as one of the biggest threats to global health, food production and economic development 1 . Given this rapidly developing global crisis, it is imperative that the current gaps in our understanding of the distribution, spread and associations of all AMR factors are filled. AMR is most often conferred through the expression of antimicrobial resistance genes (ARGs) that reduce a microbe's susceptibility to the effects of an antimicrobial compound. As such, monitoring the abundance and diversity of these ARG profiles, or the "resistome", has huge potential to increase our understanding of the spread and persistence of 49 50 considerable potential to lead to antimicrobial resistant infections at other body sites. For example, ß-lactam, clindamycin, and erythromycin resistant strains of oral streptococci have caused infections at distal body sites such as infective endocarditis 14 .
Metagenomic studies of the oral cavity indicate that this site potentially contains a diverse range of ARGs, including those encoding resistance to tetracycline, amoxycillin and gentamicin in saliva and plaque samples 15, 16 . Thus, oral ARGs appear to be natural features of the human oral cavity. The presence of an oral resistome containing aminoglycoside, ß-lactam, macrolide, phenicol and tetracycline ARGs in isolated Amerindian communities and ancient humans, indicates that the presence of these genes is not dependent on antibiotic exposure and is an inherent feature of the oral microbiome 17, 18 .
The oral microbial community faces unique ecological pressures, such as mechanical force, nutritional availability, pH levels, oxidative stress and redox potential. Despite these continually changing conditions, these communities have been shown to be relatively stable even after shortterm antibiotic exposure. Horizontal gene transfer (HGT) has been documented as an important mechanism for the transfer and acquisition of ARGs within and between oral bacterial species 19, 20 .
The erythromycin resistance mefA and mefE genes have been found on the MEGA mobile genetic element associated with Tn916-like conjugative transposons (also called integrative conjugative elements ICE), and this has been implicated in conjugative transfer between viridans group streptococci (VGS) and other streptococci diaminopyrimidine, lincosamide, macrolide, streptogramin and tetracycline ARGs, although most of these ARG classes are found in lower percentages of Fiji stool samples. Compared to oral samples, stool samples contain a lower proportion of the fluoroquinolone ARG class but higher proportions of cephalosporin and diaminopyrimidine ARG classes exclusively consisting of CblA-1 and dfrF ARGs, respectively ( Supplementary Fig. 1c ). In addition to the US stool samples containing the fewest number of ARG classes, they also contain a low proportion (less than 50 %) of fluoroquinolones, penams, penems, peptide and phenicols ARG classes compared to China, Fiji and Western Europe. Antibiotic efflux, inactivation, target alteration, target protection and antibiotic target replacement mechanisms are present in all samples across all cohorts, but the reduced permeability to antibiotic mechanism is not found in the US (Fig. 1f ).
To determine whether there are differences in ARG composition between oral and gut samples as well as between countries, the ARG incidence profiles, i.e. resistotypes, for every sample were summarised using Principal Coordinates Analysis. Resistotypes were extracted using hierarchical clustering and silhouette analysis 30 . Four resistotypes in total were identified (Fig. 2a, b) . Oral samples are mainly found in two major resistotypes, R2 and R4. R2 is comprised of mainly buccal mucosa and saliva, and R4 contains mainly dental plaque and dorsum of tongue. All stool samples are found in only two major resistotypes, R1 and R3. R1 consists of mostly stool and saliva from Fiji, whereas R3 contains mainly stool from China, Fiji, US and Western Europe.
To evaluate whether the resistome is related to antibiotic prescription rates, the abundance of ARGs for every ARG class was compared to the "Defined Daily Doses Per 1000 individuals" of equivalent drug classes for each region. Prescription data were derived from ResistanceMap (https://resistancemap.cddep.org/). This comparison indicates that overall ARG class abundance does not follow a significant linear relationship with antibiotic prescriptions for any country and body site (Fig. 2c, Supplementary Table 1 ).
The availability of longitudinal oral and stool samples from US individuals who had not taken antimicrobial agents over two years afforded us the ability to investigate the stability of resistomes without antibiotics. Hierarchical clustering reveals that the same individuals and body sites cluster together, verifying that resistomes at all sites remain stable over a prolonged period with no antimicrobial selection pressure ( Supplementary Fig. 2 ).
Comparisons between oral and gut resistomes reveal differences in ARG composition,
abundance and diversity
To further investigate the differences between oral and gut resistome profiles, the abundance and diversity between oral and gut samples from China, Fiji, US and Western Europe were evaluated and compared. The total abundance, measured as the total Reads Per Kilobase Million (RPKM), of all ARGs in gut samples is lower than in oral (buccal mucosa, dental plaque, dorsum of tongue and saliva) samples across all pairwise comparisons in all cohorts (Fig. 3a) . The overall abundance is similar between paired US oral sites, with buccal mucosa and dental plaque having a slightly higher abundance than the tongue dorsum samples (Supplementary Fig. 3 ). Oral samples contain a higher relative abundance of ARGs coding for fluoroquinolone efflux pumps, lincosamide/streptogramin/pleuromutilin resistance, macrolide efflux pumps and macrolide/lincosamide resistance than stool samples (Fig. 3b, Supplementary Fig. 4 ). These classes are mostly dominated by one of two ARGs across all cohorts, such as patB (coding for part of the PatA-PatB efflux pump) in the fluoroquinolone efflux pump class ( Supplementary Fig. 5a , b, c, d).
Stool contains a higher proportion of tetracyclines and "Other" ARGs across all cohorts ( As well as differences between oral and gut, differentially abundant ARGs were found between different sites in the oral cavity ( Supplementary Fig. 6 ). For example, between the US dorsum of tongue and plaque samples, and between the US dorsum of tongue and buccal mucosa, all ARGs are enriched in the dorsum of the tongue. Similarly, between dental plaque and buccal mucosa, all To investigate ARG diversity further, the ARG richness was evaluated between pairwise comparisons of sample types for each cohort with ARG richness defined as the number of unique ARGs per sample. Although there are no significant difference between saliva and stool samples from Fiji and Western Europe, both Chinese and US samples have significant differences in ARG richness. China and US stool samples have a significantly higher ARG richness than paired China plaque and saliva, and paired US plaque and buccal mucosa (Mann-Whitney, paired, two-sided ttest, p-value < 0.05) (Fig. 4) . In contrast, the US dorsum of tongue contains a significantly higher ARG richness than US stool. Between oral sites, Chinese saliva has a greater ARG richness than paired dental plaque (Mann-Whitney, paired, two-sided t-test, p-value < 0.05). In addition, US dorsum of tongue has a higher ARG richness than both plaque and buccal mucosa, whilst plaque has a greater ARG richness than buccal mucosa (Mann-Whitney, paired, two-sided t-test, p-value < 0.05). It is important to note that while ARG richness only measures the gene incidence regardless of expression, multiple ARGs have the potential to be involved in the expression of a single efflux pump complex, meaning ARG richness may overestimate this potential expression. Therefore, to determine the impact of this overestimation, the analysis was repeated to exclude ARGs that regulate or are part of an efflux pump complex. The differences in ARG richness have the same significance across all paired samples and countries ( Supplementary Fig. 8 ).
thus may underestimate antimicrobial use 32, 33 . In addition, antibiotics are widely used in husbandry and the fishing industry with poorly understood impacts on AMR incidence and dynamics in humans [34] [35] [36] . Prescription levels for a particular antibiotic are unlikely to be of significant value in the surveillance of AMR in the regional community. Instead, determining the population resistome is significantly more informative 37 .
The abundance and diversity of ARGs at different body sites is also of interest. Although, there are significantly more distinct ARGs in stool compared to oral samples, those ARGs present at the highest relative abundances exist in oral samples. There are several potential reasons why this may be. It is notable that many sites in the oral cavity (e.g. plaque and tongue dorsum) host highly complex and robust microbial biofilm structures. It has been posited that the compact structure of microbes within oral biofilms is a conducive environment for the aquistion of ARGs and their HGT within biofilms 38 . Likewise, the generally protective nature of biofilms against antimicrobial drugs may favour ARG acquisition. It is notable that the dorsum of tongue contains a higher diversity of these genes than other oral sites. This may be explained by the unique papillary structure on the dorsum of the tongue which acts as complex microbiological niche favouring the deposition of oral debris and microbes 39 , thus giving rise to a richer microbial community with potentially greater numbers of transient microbes. Another reason could be the difference in species resident in the gut compared to the oral cavity. E. coli strains in Chinese stool samples are predicted to contain a variety of ARGs, especially of the multidrug class, whereas species found in Chinese saliva were estimated to contain fewer ARGs. Due to stringent constraints of the correlation analysis, however, it was not possible to predict the origins for ARGs for all cohorts. Antibiotic use leading to acquisition of ARGs is another potential factor. Pharmacokinetics of orally administered antibiotics suggests that the oral cavity and oesophagus would be only briefly exposed to the antibiotic during swallowing, whilst the gut is exposed over a more prolonged period.As antibiotics transit through the intestinal tract, they are gradually absorbed via the intestinal epithelium into the bloodstream. Therefore, microbes in the gut exposed to antibiotics for a longer period of time due to their increased bioavailability will receive higher antibiotic selection pressures than those in the oral cavity 40 . The incidences where the oral cavity is likely to acquire ARGs from selective pressures of local antibiotics are from topical antibiotics for periodontal infections or orally-administered antibiotics being absorbed into the bloodstream.
The differences in ARG profiles across body sites has significant implications for the characterisation and interpretation of resistome studies. Previous shotgun metagenomic studies have focused almost exclusively on the resistome from the human gut [2] [3] [4] 6 . While the gut may be a diverse reservoir of ARGs, whether these genes are particularly prevalent or have the potential for expression sufficient to drive resistant infections at other body sites is not clear 41 . It is therefore imperative that to test potential applications of non-culture based metagenomic AMR surveillance, we need to characterise the resistome at different body sites with different pharmacokinetic exposures to antimicrobials. This information can then be integrated with culture-based susceptibility tests, culturomics 42 and functional metagenomic screens 43 to determine the expression potential of these ARGs. In doing so, we will obtain a more complete picture of the state of AMR within a population. , and 16 saliva and 16 stool samples from France 26, 27 ).
Methods

Metagenomic sequence data
Raw paired-end metagenomic reads from Chinese and Philippines samples were downloaded from the EBI (https://www.ebi.ac.uk/metagenomics/). Paired-end metagenomic samples from US were downloaded from https://portal.hmpdacc.org/. Raw paired-end metagenomic reads from Fiji (project accession PRJNA217052), France and Germany (project accession PRJEB28422) were downloaded from the NCBI. All US, China, Fiji and Philippines samples, and stool samples from France and Germany, were collected and sequenced as described in the following cited studies . Saliva samples from France and Germany were collected and sequenced as described in the following cited study 27 . Metadata for the samples can be found in Supplementary Table 2 .
Processing metagenomic data
The raw reads for all samples were trimmed using AlienTrimmer 0. 
Extracting ARGs
All processed metagenomes were mapped against nucleotide_fasta_protein_homolog_model from the antimicrobial resistance database CARD 3.0.0 29 using KMA 1.2.6. Hits were extracted where the template coverage was greater than 90 %. The metagenomes were mapped against these hits using Bowtie2 2.2.5 with parameter -very-sensitive-local. Mapped reads were filtered from unmapped reads, sorted and indexed using Samtools 1.9 47 . Statistics for the number of reads mapped for each ARG were extracted using Bedtools 2.28.0 48 .
Abundance of ARGs
The reads per kilobase of read per million (RPKM) was calculated for every sample as the number of reads divided by the total number of library reads per million, then divided by the gene length in Fig. 1 Percentage of saliva samples from individuals that contain a an ARG class and b an ARG mechanism, from China (n = 18), Fiji (n = 18), the Philippines (n = 18) and Western Europe (n = 18). Percentage of dental plaque samples from individuals that contain c an ARG class and d an ARG mechanism, from China (n = 18) and the US (n = 18). Percentage of stool samples from individuals that contain, e an ARG class and f an ARG mechanism, from China (n = 18), Fiji (n = 18), the US (n = 18) and Western Europe (n = 18). Error bars are 95 % confidence intervals (CIs) that were evaluated from percentages extracted from bootstrapping samples 100 times. 3 Resistome abundance for China, Fiji, Western Europe and US. a Absolute abundance in log10 of reads per kilobase of read per million (RPKM) of ARGs for paired samples between China stool (n = 30) and dental plaque (n = 30), China stool (n = 31) and saliva (n = 31), Fiji saliva (n = 132) and stool (n = 132), US stool (n = 68) and dental plaque (n = 68), US stool (n = 69) and dorsum of tongue (n = 69), US stool (n = 64) and buccal mucosa (n = 64), and Western Europe saliva (n = 21) and stool (n = 21).. b Relative abundance of reads labelled by the top ten most abundant ARG classes across all geographical locations or "Other" classes for each sample type from China saliva (n = 33), dental plaque (n = 32) and stool (n = 72), Fiji saliva (n = 136) and stool (n = 137), Western Europe saliva (n = 21) and stool (n = 21), and US buccal mucosa (n = 87), dorsum of tongue (n = 91), dental plaque (n = 90) and stool (n = 70). c Estimated average log2 fold change of ARGs between paired dental plaque and stool, and saliva and stool samples using random effects meta-analysis across study cohorts (p-value < 0.05). Error bars are 95 % confident intervals from meta-analysis. ARGs selected for meta-analysis where adjusted p-value < 0.05 from differential abundance analysis of US and China dental plaque and stool, and China, Fiji and Western Europe saliva and stool samples. ARG richness for paired samples between China dental plaque (n = 31) and saliva (n = 31), China stool (n = 30) and dental plaque (n = 30), China stool (n = 31) and saliva (n = 31), Fiji saliva (n = 132) and stool (n = 132), US buccal mucosa (n = 78) and dental plaque (n = 78), US buccal mucosa (n = 86) and dorsum of tongue (n = 86), US dental plaque (n = 89) and dorsum of tongue (n = 89), US buccal mucosa (n = 64) and stool (n = 64), US dental plaque (n = 68) and stool (n = 68), US dorsum of tongue (n = 67) and stool (n = 67), and Western Europe saliva (n = 21) and stool (n = 21) with Mann-Whitney, paired, two-sided t-test (p-value < 0.05 as *, < 0.01 as **, < 0.005 as ***) 
